These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11476761)

  • 1. Investigation of the effects of YM-31636, a novel 5-HT3 receptor agonist, on defecation in normal and constipated ferrets.
    Ito H; Kiso T; Yuki H; Naitoh Y; Miyata K; Iwaoka K; Yamaguchi T
    Eur J Pharmacol; 2001 Jul; 424(2):151-7. PubMed ID: 11476761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the selective 5-HT(3) receptor agonist on ferret gut motility.
    Nagakura Y; Kiso T; Miyata K; Ito H; Iwaoka K; Yamaguchi T
    Life Sci; 2002 Aug; 71(11):1313-9. PubMed ID: 12106596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel 5-HT3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing abdominal pain.
    Kiso T; Ito H; Miyata K; Kamato T; Naitoh Y; Iwaoka K; Yamaguchi T
    Eur J Pharmacol; 2001 Nov; 431(1):35-41. PubMed ID: 11716840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of YM-31636, a novel 5-HT3 receptor agonist, in vitro.
    Ito H; Kiso T; Miyata K; Kamato T; Yuki H; Akuzawa S; Nagakura Y; Yamano M; Suzuki M; Naitoh Y; Sakai H; Iwaoka K; Yamaguchi T
    Eur J Pharmacol; 2000 Dec; 409(2):195-201. PubMed ID: 11104834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation.
    Imanishi N; Iwaoka K; Koshio H; Nagashima SY; Kazuta K; Ohta M; Sakamoto S; Ito H; Akuzawa S; Kiso T; Tsukamoto S; Mase T
    Bioorg Med Chem; 2003 Apr; 11(7):1493-502. PubMed ID: 12628674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats.
    Hirata T; Keto Y; Nakata M; Takeuchi A; Funatsu T; Akuzawa S; Sasamata M; Miyata K
    Eur J Pharmacol; 2008 Jun; 587(1-3):281-4. PubMed ID: 18456254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitemcinal (GM-611), an orally active motilin agonist, facilitates defecation in rabbits and dogs without causing loose stools.
    Sudo H; Ozaki K; Muramatsu H; Kamei K; Yogo K; Cynshi O; Koga H; Itoh Z; Omura S; Takanashi H
    Neurogastroenterol Motil; 2007 Apr; 19(4):318-26. PubMed ID: 17391248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
    Hirata T; Funatsu T; Keto Y; Akuzawa S; Sasamata M; Miyata K
    J Pharmacol Sci; 2008 Feb; 106(2):264-70. PubMed ID: 18296863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OTC laxative use of sodium picosulfate â results of a pharmacy-based patient survey (cohort study).
    Hinkel U; Schuijt C; Erckenbrecht JF
    Int J Clin Pharmacol Ther; 2008 Feb; 46(2):89-95. PubMed ID: 18218289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
    King GL
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1034-41. PubMed ID: 2162943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of picosulfate sodium in upper gastrointestinal examination].
    Kawai R; Yamanashi S; Mizunuma K; Tada S
    Rinsho Hoshasen; 1984 Aug; 29(8):929-31. PubMed ID: 6392620
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
    Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T
    Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the 5-HT3 receptor antagonist granisetron on estramustine phosphate sodium (Estracyt)-induced emesis in ferrets].
    Higashioka M; Yamaguchi E; Takatori S; Tanaka M; Kyoi T
    Hinyokika Kiyo; 2010 Jul; 56(7):361-5. PubMed ID: 20724808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anorectal manometry on the outcome of treatment in severe childhood constipation: a randomized, controlled trial.
    van Ginkel R; Büller HA; Boeckxstaens GE; van Der Plas RN; Taminiau JA; Benninga MA
    Pediatrics; 2001 Jul; 108(1):E9. PubMed ID: 11433088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
    Funatsu T; Takeuchi A; Hirata T; Keto Y; Akuzawa S; Sasamata M
    Eur J Pharmacol; 2007 Nov; 573(1-3):190-5. PubMed ID: 17658508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of trimebutine and YM114 (KAE-393), a novel 5-HT3 receptor antagonist, on stress-induced defecation.
    Miyata K; Ito H; Yamano M; Hidaka K; Kamato T; Nishida A; Yuki H
    Eur J Pharmacol; 1993 Dec; 250(2):303-10. PubMed ID: 8112388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of brewer's yeast cell wall on constipation and defecation in experimentally constipated rats.
    Nakamura T; Agata K; Mizutani M; Iino H
    Biosci Biotechnol Biochem; 2001 Apr; 65(4):774-80. PubMed ID: 11388452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased defecation during stress or after 5-hydroxytryptophan: selective inhibition by the 5-HT(4) receptor antagonist, SB-207266.
    Sanger GJ; Yoshida M; Yahyah M; Kitazumi K
    Br J Pharmacol; 2000 Jun; 130(3):706-12. PubMed ID: 10821802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a selective GABA(B) receptor agonist baclofen on the mu-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects.
    Suzuki T; Nurrochmad A; Ozaki M; Khotib J; Nakamura A; Imai S; Shibasaki M; Yajima Y; Narita M
    Neuropharmacology; 2005 Dec; 49(8):1121-31. PubMed ID: 16095635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: a prospective non-randomized controlled trial.
    Rodríguez de Miguel C; Serradesanferm A; López-Cerón M; Carballal S; Pozo A; Balaguer F; Cárdenas A; Fernández-Esparrach G; Ginés A; González-Suárez B; Moreira L; Ordás I; Ricart E; Sendino O; Vaquero EC; Ubré M; del Manzano S; Grau J; Llach J; Castells A; Pellisé M;
    Gastroenterol Hepatol; 2015 Feb; 38(2):62-70. PubMed ID: 25458542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.